Digest Network Come funziona
Network
/
Società
Ga
Non verificato

Galderma

Di cosa scriviamo

BiotecnologiaFarmaceuticaIndustriaSaluteSanità

58 comunicati stampa

Guarda tutti i comunicati
11/08/2026
Multimedialità
Industria
Biotecnologia
Farmaceutica
Salute
Sanità
Galderma Receives European Union Approval for Restylane® Shaype™: the First-and-Only Bone-Mimicking Hyaluronic Acid Injectable for Facial Shaping
Fonte
Galderma
Emittente
Business Wire
1.00
0
20/07/2026
Biotecnologia
Farmaceutica
Salute
Sanità
Industria
Galderma Launches Alastin® in Japan and Key Markets Across Asia Pacific, Expanding Its Footprint in the Region
Fonte
Galderma
Emittente
Business Wire
1.00
0
07/07/2026
Multimedialità
Salute
Sanità
Scienza
Biotecnologia
Analisi di mercato
Industria
Landmark Global Galderma Survey Shows 9 out of 10 People Are Affected by Skin Quality Concerns
Fonte
Galderma
Emittente
Business Wire
1.00
0
11/06/2026
Multimedialità
Analisi di mercato
Industria
Biotecnologia
Farmaceutica
Salute
Medicina - Varie
Galderma Unveils New Global Survey Data Exploring the Evolving Expectations and Experiences of Patients and Healthcare Professionals With Anti-wrinkle Treatments
Fonte
Galderma
Emittente
Business Wire
1.00
0
22/05/2026
Galderma Receives U.S. FDA Approval for Differin® Epiduo® Acne Gel Prescription-to-OTC Switch
Fonte
Galderma
Emittente
Business Wire
1.00
0
16/04/2026
Industria
Biotecnologia
Farmaceutica
Salute
Medicina - Varie
Galderma Launches New Alastin Regenerating Skin Nectar with TriHex+™, Powered by Its Next-Generation TriHex Technology® Regenerative Platform
Fonte
Galderma
Emittente
Business Wire
1.00
0
09/04/2026
Industria
Salute
Vetrine/Shopping
Fitness
Medicina - Varie
Farmaceutica
Biotecnologia
Interim Data From Two Ongoing Investigator-initiated Trials Highlight the Role of Sculptra® and Restylane® in Addressing Aesthetic Changes Associated With Weight Loss Medications and Menopause
Fonte
Galderma
Emittente
Business Wire
1.00
0
07/04/2026
Industria
Biotecnologia
Salute
Cosmesi
Pubblico Esercizio/Vendita al dettaglio
Farmaceutica
Galderma Debuts ALASTIN Signature Practices in Partnership With Leading Aesthetic Practices to Elevate Regenerative, Peri-Procedural Skincare
Fonte
Galderma
Emittente
Business Wire
1.00
0
24/03/2026
Eventi
Industria
Scienza
Tecnica
Igiene alimentare
Medicina - Varie
Biotecnologia
Sanità
Farmaceutica
Salute
AAD 2026: Galderma Showcases Latest Evidence Supporting Its Full-Spectrum, Science-Driven Solutions for Diverse Skin Needs
Fonte
Galderma
Emittente
Business Wire
1.00
0
23/03/2026
Multimedialità
Industria
Cosmesi
Pubblico Esercizio/Vendita al dettaglio
Salute
Igiene alimentare
Sanità
Farmaceutica
Biotecnologia
Galderma Receives U.S. FDA Approval for Restylane® Contour™ for the Correction of Temple Hollowing
Fonte
Galderma
Emittente
Business Wire
1.00
0

Recapiti

Social Media

Seguaci
0
Compatibilità
0